FIELD: medicine.
SUBSTANCE: invention relates to medicine and deals with method of prevention of larval stage of echinococcosis alveolaris, which includes introduction of cellular antigen from protoscolexes of Echinococcus multilocularis, where simultaneously with cellular antigen from protoscolexes of E.multilocularis biopreparation, which represents membranous fraction of epimastigotes Trypanosoma cruzi cells, is introduced subcutaneously.
EFFECT: invention ensures development of protective immune reaction, which prevents from further infection.
2 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTING SECONDARY ALVEOLAR ECHINOCOCCOSIS (HYDATIDOSIS) | 2004 |
|
RU2279274C2 |
METHOD OF IMMUNOTHERAPY FOR SECONDARY ALVEOLAR ECHINOCOCCOSIS | 2017 |
|
RU2674767C1 |
ADJUVANT COMPOSITION FOR INJECTION TISSUE HELMINTHIASIS VACCINES | 2007 |
|
RU2348427C2 |
METHOD FOR OBTAINING A PURE VIABLE CULTURE OF PROTOSCOLEXES ECHINOCOCCUS MULTILOCULARIS | 2017 |
|
RU2665781C1 |
METHOD FOR ACTIVATION OF CESTODE ONCOSPHERES FOR LABORATORY DEVELOPMENTS OF ANTIGEN | 2020 |
|
RU2725248C1 |
ANTHELMINTIC AGENT | 2001 |
|
RU2195280C1 |
METHOD FOR OBTAINING DIAGNOSTIC ANTIGEN IN CESTODES | 2002 |
|
RU2219551C1 |
METHOD FOR MODELING IMAGINAL ALVEOCOCCOSIS | 2006 |
|
RU2310923C1 |
METHOD OF TREATMENT LARVAL ECHINOCOCCOSIS OF LABORATORY ANIMALS | 2013 |
|
RU2517044C1 |
ANTHELMINTHIC AGENT | 1998 |
|
RU2153329C2 |
Authors
Dates
2017-02-06—Published
2016-04-22—Filed